Elanco Animal Health (ELAN)

AI Score

Unlock

8.44

0.00 (0.00%)

At close: Apr 17, 2025, 3:59 PM

Elanco Animal Health Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	468M	352M	345M	638M	494.7M	334M	474.8M	323.4M	258.8M
Short-Term Investments	n/a	n/a	14M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	26M	37M	30M	35.7M	21.1M	15.3M	12.3M	9M
Other Long-Term Assets	311M	315M	378M	387M	347.8M	185M	103.1M	242M	204M
Receivables	886M	1.01B	1B	1.03B	1.08B	889.9M	709.4M	601.9M	630.7M
Inventory	1.57B	1.74B	1.54B	1.37B	1.58B	1.05B	1B	1.06B	875.6M
Other Current Assets	287M	310M	394M	237M	11M	11.1M	202.7M	-1	n/a
Total Current Assets	3.21B	3.41B	3.28B	3.28B	3.42B	2.37B	2.5B	2.12B	1.95B
Property-Plant & Equipment	993M	1.03B	999M	1.06B	1.32B	955.3M	922.4M	920.3M	741.8M
Goodwill & Intangibles	8.1B	9.59B	10.84B	11.76B	12.61B	5.47B	5.41B	5.64B	5.2B
Total Long-Term Assets	9.4B	10.96B	12.21B	13.21B	14.28B	6.61B	6.45B	6.82B	6.15B
Total Assets	12.61B	14.36B	15.49B	16.48B	17.69B	8.99B	8.96B	8.94B	8.1B
Account Payables	296M	270M	390M	416M	501M	222.6M	205.2M	203.8M	228.2M
Deferred Revenue	n/a	n/a	n/a	185M	148.6M	116M	367.6M	n/a	n/a
Short-Term Debt	44M	38M	388M	294M	554.5M	24.5M	29M	n/a	n/a
Other Current Liabilities	975M	933M	924M	718M	835.2M	471.8M	736.5M	169.2M	307.5M
Total Current Liabilities	1.31B	1.24B	1.7B	1.64B	2.08B	818.5M	970.7M	632.6M	618.9M
Long-Term Debt	4.28B	5.74B	5.45B	6.03B	5.57B	2.33B	2.44B	n/a	n/a
Other Long-Term Liabilities	926M	485M	279M	406M	1.57B	127.4M	230.6M	265M	225.4M
Total Long-Term Liabilities	5.2B	6.9B	6.5B	7.3B	7.14B	2.62B	2.79B	516.9M	452.9M
Total Liabilities	6.52B	8.14B	8.2B	8.95B	9.22B	3.44B	3.76B	1.15B	1.07B
Total Debt	4.32B	5.77B	5.84B	6.32B	6.13B	2.35B	2.47B	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.05B	7.48B
Retained Earnings	-1.95B	-2.29B	-1.06B	-949M	-477.2M	84.3M	16.4M	n/a	n/a
Comprehensive Income	-771M	-266M	-392M	-209M	303M	-173.7M	-222.2M	-256.6M	-456.9M
Shareholders Equity	6.1B	6.22B	7.29B	7.54B	8.48B	5.55B	5.2B	7.79B	7.03B
Total Investments	n/a	26M	37M	30M	35.7M	21.1M	15.3M	12.3M	9M